Multi-Institutional Study to Evaluate DNA Methylation Markers for Detection of Primary Bladder Cancers in Urine Samples From a Cohort of Patients With Hematuria (CTMS 16-0094)
The primary objective of this study is to evaluate the performance of the methylation marker
panel for the detection of bladder cancer in patients with gross or microscopic hematuria.
The secondary objective is to evaluate the predictive accuracy of a risk model including clinical
factors such as age, gender, smoking history, and presence of gross versus microscopic
hematuria compared to a model incorporating the same risk factors along with the methylation